CT Screening for Lung Cancer: Diagnoses Resulting from the New York Early Lung Cancer Action Project
Abstract
Purpose: To evaluate prospectively the diagnostic performance of the New York Early Lung Cancer Action Project (NY-ELCAP) regimen in the diagnosis of early lung cancer at baseline and annual repeat computed tomographic (CT) screenings.
Materials and Methods: Informed consent and institutional review board approval were obtained for this HIPAA-compliant study of baseline and annual repeat low-dose CT screening performed with a common regimen in asymptomatic individuals at 12 institutions in New York State. All 6295 participants were aged 60 years or older, had smoked for at least 10 pack-years, had no prior cancer, had not undergone chest CT in the previous 3 years, and were medically fit to undergo thoracic surgery. Median age was 66 years, and median smoking history was 40 pack-years. The proportion (and 95% exact confidence intervals [CIs]) of subjects with a positive result, as determined by using nodule size; the diagnoses of lung cancer resulting from subsequent work-up; and the distribution by cancer stage and cell type were determined. When relevant, 95% CIs for the proportions were calculated.
Results: Initial CT imaging led to recommendations for further work-up in 14.4% (95% CI: 13.5%, 15.3%) of the 6295 baseline screenings and 6.0% (95% CI: 5.1%, 6.6%) of the 6014 annual repeat screenings. Of 101 patients in whom the diagnosis of lung cancer resulted from baseline screening and three in whom a diagnosis of lung cancer was prompted by symptoms prior to the first scheduled repeat screening, 95 (91.3%) had no clinical evidence of metastases. Of the 20 patients in whom the diagnosis of lung cancer resulted from annual repeat screening, 17 (85%) showed no evidence of metastases. Of the 134 recommended biopsies, 125 (93.3%) resulted in diagnosis of lung cancer or another malignancy, while none of the 24 biopsies performed outside of the recommendation of the regimen resulted in diagnosis of lung cancer.
Conclusion: The NY-ELCAP regimen of screening revealed that annual CT screening for lung cancer resulted in identification of a high proportion of patients with early-stage disease.
© RSNA, 2007
References
- 1
Henschke CI - 2
Grady D - 3
Henschke CI - 4
Henschke CI - 5
Henschke CI - 6
Henschke CI - 7
Henschke CI - 8
Henschke CI - 9 International Early Lung Cancer Action protocol (including flowcharts). http://www.IELCAP.org. Accessed January 29, 2007.
- 10
Henschke CI - 11
Reeves AP - 12
MacMahon H - 13
Yankelevitz DF - 14
Kostis WJ - 15
Kostis WJ - 16
Vazquez M - 17
Vazquez M - 18
Travis WD - 19 American Joint Committee on Cancer (AJCC). Lung. In: Fleming ID, Cooper JS, Hensen DE, et al, eds. Cancer staging manual. 5th ed. Philadelphia, Pa: Lippincott-Raven, 1997; 127.
- 20 Consensus of the 10th International Conference on Screening for Lung Cancer. http://www.IELCAP.org. Accessed January 29, 2007.
- 21
Shaham D - 22
Bastarrika G - 23
Sone S - 24
Sone S - 25
Sobue T - 26
Diederich S - 27
Swensen SJ - 28
Henschke CI - 29 The International Early Lung Cancer Action Program Investigators. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med 2006;355:1763–1771.
- 30 American Cancer Society. Statistics 2005: cancer facts and figures. http://www.cancer.org. Accessed October 11, 2005.